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Abstract Text: 
 
Background: Randomized trials among advanced cancer patients demonstrate 
that early palliative care integration into usual oncology care reduces symptom 
burden, improves quality of life and caregiver outcomes, and may improve 
survival. The impact of palliative care on health economics remains poorly 
defined and reported cost savings are an unintentional consequence of providing 
care aligned with patient goals. This study determined the impact of palliative 
care on healthcare costs among elderly patients with advanced cancer.  
 
Methods: We conducted a matched case-control study among Medicare 
beneficiaries with metastatic lung, colorectal, breast and prostate cancers. We 
matched patients who received a palliative care consultation to similar patients 
who did not receive a palliative care consultation. To determine the economic 
impact of a palliative care consultation we compared costs between cases and 
controls before and after the palliative care intervention. Costs included inpatient, 
outpatient, home health care, hospice, and medical equipment, and were 
adjusted to 2011 dollars. 
 
Results: Among the 2,576 patients in this study the total healthcare costs per 
patient in the 30 days before palliative care consultation was balanced between 
palliative care ($12,881) and non-palliative care control patients ($12,335). 
Palliative care intervention reduced total healthcare costs after the intervention. 
The total cost of care per patient in the 120 days after palliative care exposure 
was $6,880 compared to $9,604 for controls (28% decrease; p < 0.001). The 
economic effect of palliative care depended on timing of the consult. Palliative 
care consultation within 7 days of death decreased healthcare costs by $975, 
whereas palliative care consultation more than 4 weeks from death decreased 
costs by $5,362.  
 
Conclusions: This study demonstrates that palliative care has the capacity to 
substantially reduce healthcare expenditures among advanced cancer patients. 
Furthermore, the cost reduction depends on timing of the palliative care consult. 	
Economic Impact of Palliative Care  
Among Elderly Cancer Patients 
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		INTRODUCTION 	
166,124 patients 
diagnosed between 2000 
and 2009 with metastatic 
prostate, breast, lung, or 
colorectal cancer  
76,182 patients in 
unmatched study cohort 
3,657 palliative care 
patients 
72,525 non-palliative 
care patients 
1,288 matched pairs 
in final analysis 
		RESULTS 	
Randomized trials among advanced cancer patients demonstrate that early 
palliative care integration into usual oncology care reduces symptom 
burden, improves quality of life and caregiver outcomes, and may 
improve survival. The impact of palliative care on health economics 
remains poorly defined and reported cost savings are an unintentional 
consequence of providing care aligned with patient goals. This study 
determined the impact of palliative care on healthcare costs among 
elderly patients with advanced cancer.  
		METHODS 	
We conducted a matched case-control study among Medicare 
beneficiaries with metastatic lung, colorectal, breast and prostate cancers. 
We matched patients who received a palliative care consultation to 
similar patients who did not receive a palliative care consultation. To 
determine the economic impact of a palliative care consultation we 
compared costs between cases and controls before and after the palliative 
care intervention. Costs included inpatient, outpatient, home health care, 
hospice, and medical equipment, and were adjusted to 2011 dollars. 
Patients sequentially excluded:  
•  21,550 more than one primary tumor 
•  299 diagnosed at death  
•  21,985 alive at end of study, or dead due to non-cancer causes 
•  39,268 with non-continuous Medicare Parts A and B, or any Part C  
•  1,371 received first palliative consult on day of death 
•  5,469 with Medicare costs zero or missing 
Figure	1:	Pa,ent	Selec,on	and	Matching	
		MATCHING 	
Patients were matched on gender, age, year of diagnosis, region, time 
from diagnosis to death, and pre-exposure costs. Matched exposure 
periods were then determined for each pair. 
		DISCUSSION 	
Palliative care reduced total healthcare costs after intervention among 
Medicare beneficiaries with advanced cancer. Furthermore, the cost 
reduction depends on timing of the palliative care consult. This study 
demonstrates that palliative care has the capacity to substantially reduce 
healthcare expenditures among advanced cancer patients.  
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Among the 2,576 patients in this study the total healthcare costs per patient in the 30 days 
before palliative care consultation was balanced between palliative care ($12,881) and non-
palliative care control patients ($12,335). Palliative care intervention reduced total healthcare 
costs after the intervention. The total cost of care per patient in the 120 days after palliative care 
exposure was $6,880 compared to $9,604 for controls (28% decrease; p < 0.001). The 
economic effect of palliative care depended on timing of the consult. Palliative care 
consultation within 7 days of death decreased healthcare costs by $975, whereas palliative care 
consultation more than 4 weeks from death decreased costs by $5,362.  
Figure	2:	Eﬀect	of	Timing	of	Pallia,ve	Care	
Table	1:	Selected	baseline	characteris,cs	 Table	2:	Healthcare	costs	
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Figure	3:	Matching	Exposure	Periods	
Standardized	diﬀerences	less	than	|0.1|	indicate	minimal	imbalance	between	groups.	
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Background 
•  Randomized trials demonstrate palliative care 
integration in oncology care reduces symptom 
burden and improves quality of life1-7 
•  Palliative care decreased healthcare utilization 
among Medicare beneficiaries with advanced 
cancer 8 
•  Economic impact of palliative care has been 
understudied at the population level 
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Study 
•  Determine the impact of palliative care consultation 
on healthcare costs 
•  Matched case-control study among Medicare 
beneficiaries with metastatic lung, colorectal, 
breast and prostate cancers 
Presented by: 
Data 
•  Surveillance, Epidemiology, and End Results 
(SEER)-Medicare linked database 
•  SEER cancer registry data, compiled by the 
National Cancer Institute 
•  Linked Medicare claims data for eligible patients in 
SEER registries  
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Healthcare Costs 
•  Medicare payments used as an estimation of healthcare costs9 
•  Payments include inpatient, outpatient, home health care, 
hospice and medical equipment 
•  Payments adjusted for geographic variation (Geographic Cost 
Pricing Index and Geographic Adjusted Factor) 
•  Payments inflation-adjusted to 2011 dollars (Medicare Economic 
Index and CMS Prospective Payment System Hospital Price 
Index) 
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Patient Selection 
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166,124 patients 
diagnosed between 2000 
and 2009 with metastatic 
prostate, breast, lung, or 
colorectal cancer  
76,182 patients in 
unmatched study cohort 
Patients sequentially excluded:  
•  21,550 more than one primary tumor 
•  299 diagnosed at death  
•  21,985 alive at end of study, or dead 
due to non-cancer causes 
•  39,268 with non-continuous Medicare 
Parts A and B, or any Part C  
•  1,371 received first palliative consult on 
day of death 
•  5,469 with Medicare costs zero or 
missing 
 
3,657 palliative care 
patients 
72,525 non-palliative 
care patients 
1,288 matched pairs 
in final analysis 
Matching 
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•  Patients were matched on gender, age, year of diagnosis, 
time from diagnosis to death, and pre-exposure costs 
•  Matched exposure periods were determined for each pair 
 
Baseline Characteristics 
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Standardized differences less than |0.1| indicate minimal imbalance between groups. 
Healthcare Costs 
Control	 Palliative Care	
30 days before exposure	  $12,335 	  $12,881 	
After exposure	  $9,604 	  $6,880 	
Presented by: 
28% difference (p<0.001) in healthcare costs 
between palliative care and control groups after 
exposure 
Healthcare Costs 
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$5,362 reduction in cost in 
palliative care group 
 
Discussion 
•  Palliative care has the capacity to substantially reduce 
healthcare expenditures among advanced cancer patients 
(595,000 cancer-related deaths in 2016) 
•  Early palliative care has the potential for substantial costs 
savings if implemented across the country among cancer 
patients 
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Anthony L. Back, MD, Professor of Medicine at the University of Washington Cambia Palliative Care Center of
Excellence and the Fred Hutchinson Cancer Research Center, giving his presentation on Clinician Burnout: Why We
Need a Multilevel, Multistakeholder Response, after receiving the Walther Cancer Foundation Palliative and Supportive
Care in Oncology Endowed Award and Lecture. Photo ©ASCO/Phil McCarten 2017.
Advancing Care Across the Cancer
Continuum
By Jo Cavallo 
November 25, 2017 
Tweet this page  
ADVERTISEMENT
 
Addressing the need to integrate palliative and supportive care practices into medical specialties to
ensure optimal patient-centered care across the cancer continuum and the evidence-based remedies
to accomplish that goal were the focus of the nearly 300 study abstracts presented at the 2017 Palliative
and Supportive Care in Oncology Symposium held on October 27–28 in San Diego. As in past years, this
year’s gathering attracted over 600 attendees in multidisciplinary specialties, including oncology,
nursing, palliative care, social work, and psychiatry, as well as patients, patient advocates, and
caregivers from a variety of countries, including the United States, Canada, United Kingdom, France,
Italy, and China.
Cosponsored by ASCO, the American Academy of Hospice and Palliative Medicine (AAHPM), the
American Society for Radiation Oncology (ASTRO), and the Multinational Association of Supportive
Care in Cancer (MASCC), this year’s meeting included six general sessions, two oral abstract sessions,
and two poster sessions as well as the inaugural presentation of the Walther Cancer Foundation
Palliative and Supportive Care in Oncology Endowed Award and Lecture. 
The award was presented to Anthony L. Back, MD, Professor of Medicine at the University of
Washington Cambia Palliative Care Center of Excellence and the Fred Hutchinson Cancer Research
Center and cofounder of VitalTalk, an interactive development course for clinicians and faculty to
improve patient-clinician communication. During his presentation, Dr. Back spoke about clinician
burnout and the need for a multilevel, multistakeholder response to the problem, which a|ects more
than 45% of oncologists and 62% of palliative care specialists and is on the rise, according to Dr. Back. 
Ą
­
¬
â
3/7/2018 Advancing Care Across the Cancer Continuum - The ASCO Post
http://www.ascopost.com/issues/november-25-2017/advancing-care-across-the-cancer-continuum/ 2/8
Eric Roeland, MD,
FFHPM
Andrew Epstein, MD
“[Physician] burnout is a systemic problem, and we need to take action now,” said Dr. Back.
“Clinicians can build resilience with training and practice … to make you less susceptible to the
stressors you face every day.” Clinicians can augment their resilience skills, said Dr. Back, by managing
their energy level during the day through improving sleep patterns, using attention mindfully, nding
healthy boundaries, reframing cognitive distortions, calibrating expectations, regulating emotions,
and discovering meaning in everyday life. 
Prognostication in the Era of Immunotherapy
The general sessions at this year’s meeting focused on the integration of innovative models of
oncology and palliative care; the unique supportive and palliative care challenges of treating older
adults with cancer; symptom management to address issues such as insomnia, fatigue, and nausea;
opioid risk assessment and management; sexual health; and palliative radiation therapy and palliative
surgery. The symposium also included an important breakout session on palliative and supportive care
in the immunotherapy era and featured a presentation by Eric Roeland, MD, FFHPM, Assistant Clinical
Professor at the University of California, San Diego, on the di}culty of prognostication in the setting
of immunotherapy. 
“Our ability to accurately prognosticate the course of a
patient’s cancer trajectory is more challenging now that we
have therapies that are sometimes producing better results
than the results we were getting with the more conventional
cytotoxic chemotherapies,” said Andrew Epstein, MD, Chair
of the 2017 Palliative and Supportive Care in Oncology
Symposium News Planning Team and Assistant Attending
Physician at Memorial Sloan Kettering Cancer Center. “But
we have to be mindful that, unfortunately, immunotherapy
and other precision medicine therapies are not currently beneting the majority of patients with
cancer. And we have to be even more patient-centered in our delivery of care, as we become more
hopeful about the molecular underpinnings that may be leveraged for some patients.” 
He continued, “I liked Dr. [Eric] Roeland’s model using [the clinician’s] gut, brain, and heart as a
necessary combination of human factors to best guide patients in prognostication about their cancer.
We need to always keep his motto in mind: Hope for the best, prepare an emergency plan, and expect
the unexpected.”
Financial Benet of Early Palliative Care
The results from several study abstracts drew particular attention at this year’s symposium, including
a study by Wendi G. Lebrett, BA, a medical student at the University of California, San Diego, and her
colleagues, on the economic impact of early palliative care among elderly patients with advanced
cancer. The ndings from her study show that the economic impact of palliative care depended on the
timing of the consultation. For example, a palliative care consultation within 7 days before death
decreased health-care costs by $975. However, a palliative care consultation more than 4 weeks from
death decreased costs by more than $5,000 (see page 67 for more on this study).
1 
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Anne Katz, PhD, RN,
FAAN
“The ndings from this study parallel the ‘value in cancer
care’ equation, which ASCO has embraced as a very
important factor in not only improving the benets of care,
but in decreasing health-care costs, as well,” said Dr.
Epstein. “What was new from Wendi Lebrett’s presentation
is that the economic impact was shown on a population
level, which is important to realize, especially as we recently
have seen di|erent models of medical care emerging that
are more value-based than volume-based.” 
The oral abstract sessions showcased studies on the positive e|ects of early integrated palliative care
on patients’ coping skills, quality of life, and depression  as well as interventions to improve
psychosocial outcomes in adolescents and young adults with cancer.  These presentations provided
evidence on how palliative care is e|ective in giving patients the emotional tools necessary to cope
with a cancer diagnosis and in improving patient-centered outcomes.
New this year was a general session devoted exclusively to sexual health, intimacy, and palliative care,
including what research is showing in sexual health and body image, interventions to facilitate sexual
health, and how to overcome the di}culty of talking with patients about the potential sexual side
e|ects of cancer and its treatment.
“Sexuality … is still something considered taboo in oncology care and perhaps
even more so in palliative care,” said Anne Katz, PhD, RN, FAAN, a certied
sexuality counselor at CancerCare Manitoba, during her presentation, “Talking
About Sexuality With Patients: Models, Myths, and Motivations.” She cited
research showing that nearly half of patients with cancer never talk to their
health-care provider about their sexual health concerns.  
Educating patients about all the potential side e|ects of cancer and its treatment,
including sexual dysfunction, and their impact on patients’ quality of life is
critical in providing high-quality oncology care. “I believe we have an absolute
and fundamental responsibility to talk about the sexual consequences of treatment because we talk
about all the other consequences, too,” said Dr. Katz.
Maintaining a Personal Touch 
Also presented at the symposium was new research examining patient-physician communication and
the preference of patients with advanced cancer to have their physicians speak with them face-to-face,
with just a notepad in their hand to record their interaction rather than repeatedly turning to a
computer to input information. The result of the randomized clinical trial shows that patients
perceived physicians who communicated face-to-face without the use of a computer as being more
compassionate, professional, and having better communication skills.
“This study is a reminder to all of us to minimize as much as possible the interruptions that often come
with the use of technology when we are communicating directly with patients,” said Dr. Epstein.
The importance of personalizing care for patients through face-to-face interaction and the impact of
[Physician] burnout is a
systemic problem, and we
need to take action now.
— Anthony L. Back, MD
Tweet this quote  
“
2
3
4
5
3/7/2018 Advancing Care Across the Cancer Continuum - The ASCO Post
http://www.ascopost.com/issues/november-25-2017/advancing-care-across-the-cancer-continuum/ 4/8
Angelo E. Volandes, MD, MPH, Assistant Professor of Medicine at Massachusetts General Hospital, giving his keynote
lecture on The Conversation: A Revolutionary Plan for End-of-Life Care. The misalignment between the type of care
people want at the end of life and the care they actually receive is the most urgent problem in health care today, said Dr.
Volandes. Photo ©ASCO/Phil McCarten 2017.
Wendi G. Lebrett, BA, presents the results from her study on the economic impact of early palliative care among elderly
patients with advanced cancer (Abstract 91), at the Palliative and Supportive Care in Oncology Symposium on October
27, 2917. Photo ©ASCO/Phil McCarten 2017.
technology on patient care was also the subject of the keynote lecture by Angelo E. Volandes, MD,
MPH, Assistant Professor of Medicine at Massachusetts General Hospital, and author of The
Conversation: A Revolutionary Plan for End-of-Life Care.  
Despite the fact that most people (90%) want to die at home, two-thirds of patients over age 65 die in
the hospital, said Dr. Volandes. That misalignment between the type of care people want and the care
they actually receive is what Dr. Volandes considers the most urgent problem in American health care
today.
Dr. Epstein agreed. “Patient centeredness has always been important, but in this age of more
sophisticated technology to diagnose and treat our patients, we have to become patient-centered in
terms of really knowing who the patient sitting in front of us is and what is important to him or her as
the disease takes its course, including at the end of life,” said Dr. Epstein. “As physicians, we have to do
a better job of inquiring what our patients’ concerns are and assuring them that we will do our best to
address those concerns.” 
Providing Optimal Care for Patients
The overarching theme throughout the 2-day symposium was the promotion of the integration of
palliative and supportive care practices for patients with cancer from diagnosis through survivorship
and end of life utilizing both a multi- and interdisciplinary approach. 
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Jamie H. Von Roenn,
MD, FASCO
MORE ON PHYSICIAN BURNOUT
For more on physician burnout and
how to protect against the problem,
see an interview with Anthony L. Back,
MD, on The ASCO Post Newsreels at
www.ascopost.com/videos.
 
SAVE THE DATE
Next year’s Palliative and Supportive
Care in -Oncology -Symposium will be
held on -November 16–17, 2018,  
in San Diego.
“This year’s Palliative and Supportive Care in Oncology Symposium highlighted
the need for collaboration among specialties for the provision of optimal oncology
care,” said Jamie H. Von Roenn, MD, FASCO, ASCO’s Vice President of Education,
Science, and Professional Development. “The presentations and discussions of
the di}culty of prognostication in this era of precision medicine, prescribing
opioids in the midst of an opioid crisis in the United States, and improving patient
outcomes with integrated palliative and oncology care underscored this point.” 
DISCLOSURE: Drs. Back, Epstein, Katz, Volandes, and Von Roenn, and Ms. Lebrett,
reported no conicts of interest.
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Palliative Care Intervention Reduces
Total Health-Care Costs in Patients With
Advanced Cancer
By Chase Doyle 
November 25, 2017 
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A matched case-controlled study among Medicare beneciaries with metastatic lung, colorectal,
breast, and prostate cancers has found that palliative care consultation signicantly reduced total
health-care costs following intervention. According to data presented at the 2017 Palliative and
Supportive Care in Oncology Symposium,  the average total cost of care for patients after receiving
palliative care at any time over the course of their treatment was $6,880 compared to $9,604 for
controls (P < .001). Moreover, the authors reported that the economic e|ect of palliative care depended
on the timing of the consult. Palliative care consultation within 7 days of death decreased health-care
costs by $975, whereas palliative care consultation more than 4 weeks from death decreased costs by
$5,362.
“If we apply the average $3,000 cost savings to the 600,000 cancer-related
deaths in 2016, this approximates to $1.8 billion in potential cost savings,” said
Wendi G. LeBrett, BA, a medical student at the University of California, San Diego.
“Palliative care has the capacity to substantially reduce health-care costs among
advanced cancer patients, and early palliative care in particular appears to be a
key driver in determining the magnitude of potential cost reduction.”
Although randomized trials have demonstrated that early palliative care
integration into usual oncology care reduces symptom burden, improves quality of life and caregiver
outcomes, and may improve survival,  as Ms. LeBrett reported, the impact of palliative care on health
economics remains poorly dened. 
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IMPACT OF PALLIATIVE CARE
ON COSTS
The average total cost of care per
patient after palliative care exposure
decreased by 28% compared to control
(P < .001).
The economic effect of palliative care
depended on the timing of the consult.
“Our group recently published a study showing that
palliative care is associated with decreased health-care
utilization in patients with advanced cancer,” said Ms.
LeBrett. “The next logical step was to see what fewer
health-care interventions actually meant in terms of dollars
and cents.”
SEER-Medicare Linked Data Analysis
In order to quantify the economic impact of palliative care,
Ms. LeBrett and colleagues used data from the Surveillance,
Epidemiology, and End Results (SEER)-Medicare Linked
Database, compiled by the National Cancer Institute.
Starting with 166,124 Medicare beneciaries diagnosed
between 2000 and 2009 with metastatic lung, colorectal,
breast, and prostate cancers, the researchers excluded
patients who met at least one of the following criteria: more than one primary tumor; diagnosis at
death; alive at the end of the study; death due to noncancer causes; or noncontinuous or missing
Medicare coverage. Patients who received their rst palliative consult on the day of their death (n =
1,371) were also excluded.
After applying these exclusion criteria, investigators
were left with 3,657 palliative care patients, as the vast
majority of patients (n = 72,525) had not received
palliative care. Ms. LeBrett and colleagues then matched
patients who received a palliative care consultation with
an appropriate control in the non–palliative care group.
Patients were matched on gender, age, year of diagnosis,
region, time from diagnosis to death, and preexposure
costs. Matched exposure periods were then determined
for each pair. Investigators included 1,288 matched pairs
in the nal analysis. 
“We used Medicare payments as an estimation of health-care costs,” said Ms. LeBrett, who noted that
researchers were interested in analyzing all direct medical costs. “These costs included inpatient,
outpatient, home health care, hospice, and medical equipment, and they were adjusted to 2011 dollars
as well as geographic variation.”
Although selected baseline characteristics for both groups were well balanced, said Ms. LeBrett, 67% of
patients in the palliative care group received care from a teaching hospital compared to 58% in the
control. According to Ms. LeBrett, this outcome is consistent with the literature, which has shown that
patients who receive palliative care are also more likely to be treated at a teaching hospital. 
Decreased Health-Care Costs With Palliative Care
Palliative care has the
capacity to substantially
reduce health-care costs
among advanced cancer
patients, and early palliative
care in particular appears to
be a key driver in
determining the magnitude
of potential cost reduction.
— Wendi G. LeBrett, BA
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As Ms. LeBrett reported, total health-care costs per patient in the 30 days before palliative care
consultation were balanced between palliative care ($12,881) and non–palliative care control patients
($12,335). Following the intervention, however, palliative care intervention reduced health-care costs
by 28% (P < .001). 
“After exposure to palliative care, patients in the palliative care group consistently had lower average
daily costs than their control counterparts,” said Ms. LeBrett. “On average, this resulted in
approximately a $3,000 reduction in overall cost in the palliative care group compared to control.”
The total cost of care per patient after palliative care exposure was $6,880, compared to $9,604 for
controls. According to the authors, the timing of palliative care was also a signicant factor in
determining the magnitude of health-care cost reduction. Patients who -received palliative care within
7 days of death had an average $975 reduction in overall health-care costs compared to matched
counterparts, whereas palliative care consultation more than 4 weeks from death decreased costs by
$5,362.
“We believe these di|erences in costs based on timing are due to the fact that this is a longer length of
time that palliative care can have an e|ect and change behavior,” Ms. LeBrett observed.
Benets Beyond Symptom Management
According to Keith Mark Swetz, MD, MA, FACP, FAAHPM, HMDC, Associate Professor of Medicine and
Section Chief of Palliative Care at the Birmingham VA Hospital, University of Alabama School of
Medicine, the study by LeBrett et al demonstrates that palliative care o|ers benets beyond concrete
symptom management and improved quality of life.
“Based on these data, there also are substantial nancial benets that can be had
with palliative care,” said Dr. Swetz, who noted that successful palliative care
intervention ultimately comes down to the patients. “While we’re looking for
consistency, we must remember that we are dealing with individual patients with
individual needs. We want to make sure that we give them the opportunity to
address those needs.”
Eduardo Bruera, MD, FAAHPM, Medical Director, Department of Supportive Care
Center, The University of Texas MD Anderson Cancer Center, Houston, added that this research
provides palliative care clinicians with another way to justify their work.
“We can take advantage of this methodology and apply it at our own centers to show the cost benets
of palliative care,” said Dr. Bruera. 
DISCLOSURE: Ms. LeBrett, Dr. Swetz, and Dr. Bruera reported no conicts of interest. 
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SAN DIEGO, California ― Palliative care can substantially reduce healthcare costs for
advanced cancer patients, and when initiated early, it is a key driver in lowering expenditures,
according to a new study.
"To put it into context, we took the average savings of approximately $3000 per patient [found
in the study] and applied it to the 595,000 cancer deaths in 2016," said lead author Wendi G.
Lebrett, a medical student at the University of California, San Diego. "That is approximately
$1.8 billion in cost savings, and this helps highlight the impact of palliative care."
Lebrett presented the ﬁndings of her study at the Palliative Care in Oncology Symposium
(PCOS) 2017.
A number of recent studies have investigated the impact of palliative care on healthcare
utilization and its potential for reducing costs. One study conducted at Johns Hopkins
Medicine found that opening a palliative care unit saved the facility $367,751 in direct costs.
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Another study showed that palliative care substantially reduces aggressive end-of-life care
compared with end-of-life care with no palliative component, which in turn would lower related
costs.
Lebrett explained that her group has also previously found that palliative care decreases
healthcare utilization, so "the next logical question is that if it decreases utilization, then what
does this mean in dollars and cents?"
Quantifying the impact of palliative care has been understudied by investigators, she pointed
out.
The Earlier the Palliative Care, the Lower the Cost
To determine the impact of palliative care ― and of the timing of that care ― on healthcare
costs among elderly patients with advanced cancer, Lebrett and colleagues compared cost
between case patients and control patients before and after the palliative care intervention. All
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direct costs were included, such as costs associated with inpatient, outpatient, and home
healthcare, as well as hospice care and medical equipment.
Using SEER data, they identiﬁed 166,124 elderly patients with advanced disease. After
applying exclusion criteria, about 3600 patients had received palliative care. "The vast majority
― 72,000 ― had not," she said.
They further excluded about 1400 patients because they had their ﬁrst palliative care consult
on the day of their death, and therefore the timing was not sufﬁcient for that care to have had
an impact on their healthcare costs.
The ﬁnal analysis included 1288 matched pairs.
The demographics were balanced between the two groups, but more of the palliative care
patients had been treated in a teaching hospital compared to the control patients (67% vs
58%).
"This is consistent from what we know in the literature, that patients who receive palliative
care are also more likely to be treated at a teaching hospital," she pointed out.
Among the entire cohort of 2576 patients (ie, the matched pairs), the total healthcare costs per
patient in the 30 days before palliative care consultation were similar between palliative care
patients ($12,881) and control patients ($12,335).
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However, after the initiation of palliative care, total healthcare expenditures declined. The total
cost of care per patient in the 120 days after palliative care began was $6880 vs $9604 for
control patients ― a 28% decrease in spending (P < .001).
Timing of palliative care was very important with respect to cost. When a palliative care
consultation took place within 7 days of death, healthcare costs declined by $975, but when
the palliative care consultation occurred more than 4 weeks before death, costs decreased by
$5362.
"The palliative care patients had consistently lower average daily costs compared to controls,"
said Lebrett. "Timing of care was a signiﬁcant factor in determining the magnitude of savings
in cost."
High Priority and Skill Set Needed
Approached for an independent comment, Steven D. Pearson, MD, president, Institute for
Clinical and Economic Review, Boston, Massachusetts, explained that making high-quality
palliative care available to patients with cancer should be a high priority for all clinicians,
provider groups, and insurers.
"The evidence continues to pile up that it can improve patient outcomes and reduce costs, but
there are structural problems with the way that care is paid for and in the ability to identify
high-quality providers of palliative care," he told Medscape Medical News. "There is also a gap
in the awareness and ability of clinicians to integrate palliative care into their practices.
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"Many clinicians think they can do it themselves, but there is a clearly deﬁned skill set that
really requires speciﬁc training, and so most oncologists will need to ﬁgure out how to
collaborate with clinicians ― but not necessarily physicians ― who can provide these services
in a seamless way," Dr Pearson added.
Wendi Lebrett has disclosed no relevant ﬁnancial relationships. Dr Pearson is president of the
Institute for Clinical and Economic Review.
Palliative Care in Oncology Symposium (PCOS) 2017. Abstract 91, presented October 27,
2017.
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